Methods and prognostic value of bone marrow examination in small cell carcinoma of the lung
Authors:
Abstract
The technique and predictive value for survival of initial and restaging bone marrow examinations in small cell carcinoma (SCC) of the lung were evaluated by 76 examinations of 72 patients. In 76 examinations, only 2 (2.6%) of the bilateral iliac crest bone marrow examinations revealed tumor cells unilaterally and these two were restaging examinations. If SCC was found in the marrow, bone marrow biopsy was always positive. In no instance was an aspirate positive with a negative bone marrow biopsy. Thus a unilateral bone marrow biopsy is an adequate technique for the initial staging of the bone marrow in SCC of the lung. Survival of patients with or without positive initial bone marrow examinations was not significantly different. Cancer 53:99‐102, 1984.Keywords
This publication has 18 references indexed in Scilit:
- Bronchoscopy and Bone Marrow ExaminationsChest, 1981
- Small cell lung cancerThe American Journal of Medicine, 1979
- Bone-marrow examination in the staging of small-cell anaplastic carcinoma of the lung with special reference to subtyping:An evaluation of 203 consecutive patientsCancer, 1977
- Frequency and significance of bone marrow involvement by metastatic solid tumorsCancer, 1977
- Management of small cell carcinoma of the lung.Therapy, staging, and biochemical markersCancer, 1976
- Small cell anaplastic carcinoma of lung.Reappraisal of current managementCancer, 1976
- Small cell carcinoma of the lung: Staging, paraneoplastic syndromes, treatment, and survivalCancer, 1974
- Staging of inoperable patients with bronchogenic carcinoma with special reference to bone marrow examination and peritoneoscopyCancer, 1972
- Value of the bone marrow biopsy in the diagnosis of metastatic carcinomaCancer, 1972
- Nonparametric Estimation from Incomplete ObservationsJournal of the American Statistical Association, 1958